Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-10-012505
Filing Date
2010-03-05
Accepted
2010-03-05 16:35:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a10-5216_1424b5.htm 424B5 523510
2 GRAPHIC g52161hui001.jpg GRAPHIC 4395
3 GRAPHIC g52161hoi001.jpg GRAPHIC 4395
4 GRAPHIC g52161bei001.jpg GRAPHIC 4395
  Complete submission text file 0001104659-10-012505.txt   543608
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-159606 | Film No.: 10661160
SIC: 2836 Biological Products, (No Diagnostic Substances)